Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) Return on Capital Employed: 2020-2023

Historic Return on Capital Employed for Therapeutics (RAPT) over the last 3 years, with Dec 2023 value amounting to -0.77%.

  • Therapeutics' Return on Capital Employed fell 39.00% to -0.77% in Q4 2023 from the same period last year, while for Dec 2023 it was -0.77%, marking a year-over-year decrease of 39.00%. This contributed to the annual value of -0.64% for FY2023, which is 25.00% down from last year.
  • Therapeutics' Return on Capital Employed amounted to -0.77% in Q4 2023, which was down 22.89% from -0.63% recorded in Q3 2023.
  • Over the past 5 years, Therapeutics' Return on Capital Employed peaked at -0.30% during Q3 2021, and registered a low of -0.77% during Q4 2023.
  • Over the past 3 years, Therapeutics' median Return on Capital Employed value was -0.40% (recorded in 2022), while the average stood at -0.46%.
  • In the last 5 years, Therapeutics' Return on Capital Employed increased by 15bps in 2022 and then tumbled by 39bps in 2023.
  • Quarterly analysis of 4 years shows Therapeutics' Return on Capital Employed stood at -0.47% in 2020, then increased by 13bps to -0.35% in 2021, then declined by 3bps to -0.38% in 2022, then tumbled by 39bps to -0.77% in 2023.
  • Its Return on Capital Employed was -0.77% in Q4 2023, compared to -0.63% in Q3 2023 and -0.48% in Q2 2023.